
204: In the Bloodstream: Diagnosing Infections Faster
About this episode
Bloodstream infections can progress rapidly to sepsis—bringing high costs, high mortality, and lasting effects. In the second episode of this series in collaboration with bioMérieux, Luis speaks with Dr. Jeff Cies, Senior Medical Advisor at bioMérieux, about how molecular diagnostics are reshaping bloodstream infection diagnosis.
They discuss:
-
Limitations of traditional blood cultures
-
How rapid molecular tests deliver results faster than ever
-
The impact on outcomes, costs, and antimicrobial resistance
-
The role of stewardship programs in maximizing results
-
What the future holds: direct-from-blood testing, nanotechnology, and AI
A powerful look at how innovation in microbiology is changing the fight against sepsis and saving lives.
This episode is sponsored by bioMérieux, a global innovator in infectious disease diagnostics.
Resources from this episode:
Stay connected with Let's Talk Micro:
-
Website: letstalkmicro.com
-
Questions or feedback? Email me at [email protected]
Support the podcast:
Get every episode summarized
Each time Let's Talk Micro publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Let's Talk Micro

242: Microbiology & Infection Prevention: Partners in Crime
Let's Talk Micro

241: What Can Whole Genome Sequencing Realistically Tell Us About Resistance?
Let's Talk Micro

240: CLSI M100 2026: Actualizaciones
Let's Talk Micro

239: Inside ASM Microbe 2026
Let's Talk Micro